Vitamin D deficiency in a man with multiple myeloma

North American Journal of Medical Sciences

Volumn 3, Issue 10, 2011, Pages 469-471

  Clement, Zackariah ^a   Ashford, Meeghan ^a   Sivakumaran, Seeva ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Multiple myeloma; Musculoskeletal pain; Vitamin D deficiency

Indexed keywords

ALKALINE PHOSPHATASE; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; LENALIDOMIDE; MELPHALAN; PARATHYROID HORMONE; VINCRISTINE; VITAMIN D; VORINOSTAT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DISEASE; BONE TENDERNESS; CASE REPORT; DEPRESSION; DETERIORATION; DRUG MEGADOSE; FALLING; FUNCTIONAL STATUS; GAIT DISORDER; HERPES ZOSTER; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOCOMOTION; MALE; MALIGNANT TRANSFORMATION; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MUSCLE WEAKNESS; MUSCULOSKELETAL CHEST PAIN; MUSCULOSKELETAL PAIN; OSTEOMALACIA; PALLOR; PARATHYROID HORMONE BLOOD LEVEL; PHYSIOTHERAPY; PLASMACYTOMA; PLASMAPHERESIS; REHABILITATION CARE; SALVAGE THERAPY; TREMOR; TUMOR LYSIS SYNDROME; VIRUS REACTIVATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WEIGHT BEARING; WEIGHT REDUCTION;

EID: 80053444707     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.3469     Document Type: Article

References (15)

1. Roodman GD. Myeloma bone disease: pathogenesis and treatment. Oncology 2003; 19:983-984.
2. Ng AC, Kumar SK, Rajkumar SV, et al. Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 2009; 84(7): 397-400.
3. Diamond T, Golombick T, Manoharan A. Vitamin D status may affect the skeletal complications of multiple myeloma. Am J Hematol 2010; 85 (4): 302-303.
4. Badros A, Goloubeva O, Terpos E, Milliron T, Baer MR, Streeten E. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008; 142 (3): 492-494.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 337(3): 266-281.
6. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94(1): 26-34.
7. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88: 37-66.
8. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.
9. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169 (6): 551-561.
10. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986;7: 434-448.
11. Souberbielle JC, Friedlander G, Kahan A, et al. Evaluating vitamin D status, implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73: 249-233.
12. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b3692.
13. Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 33: 234-239.
14. Sanders KM, Stuart AL, Williamson, EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303:1815-1822.
15. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98:451-459.